Here is a complete overview of what Ozempic is used for:
Ozempic (Semaglutide) Injection - Uses
Ozempic is a GLP-1 receptor agonist (glucagon-like peptide-1). It mimics the natural incretin hormone GLP-1, which the gut releases after a meal.
1. Type 2 Diabetes (Primary FDA-Approved Use)
Ozempic is injected once weekly as an adjunct to diet and exercise to improve blood sugar (glycemic) control in adults with type 2 diabetes. It works by:
- Stimulating glucose-dependent insulin secretion (more insulin when blood sugar is high)
- Slowing gastric emptying, which reduces the spike in blood sugar after meals
- Reducing glucagon (the hormone that raises blood sugar)
- Promoting beta-cell proliferation (the insulin-producing cells of the pancreas)
- Reducing food intake by enhancing satiety (feeling full)
As a result, it lowers post-meal blood sugar levels and HbA1c (a long-term blood sugar marker).
- Lippincott Illustrated Reviews: Pharmacology, p. 808
2. Cardiovascular Risk Reduction
Ozempic is also approved to reduce the risk of major adverse cardiovascular events - specifically:
- Heart attack (non-fatal myocardial infarction)
- Stroke (non-fatal)
- Cardiovascular death
This applies to adults with type 2 diabetes who also have established cardiovascular disease.
- Lippincott Illustrated Reviews: Pharmacology, p. 808
3. Obesity / Weight Loss
At higher doses, injectable semaglutide is approved for chronic weight management in people with obesity or overweight. For this indication, the brand name is Wegovy (same drug, higher dose than Ozempic). However, Ozempic itself is frequently used off-label for weight loss due to its satiety-enhancing effects.
It reduces hunger by acting on GLP-1 receptors in both the gut and the brain, leading to decreased caloric intake.
- Lippincott Illustrated Reviews: Pharmacology, p. 809
- Kaplan & Sadock's Comprehensive Textbook of Psychiatry
4. Kidney Protection (Emerging/Expanding Indication)
Recent data (as of 2025) show semaglutide also offers kidney (renal) protection in patients with type 2 diabetes and chronic kidney disease, and this is an area of expanding indications.
Quick Summary Table
| Use | Approved? | Notes |
|---|
| Type 2 Diabetes (blood sugar control) | Yes (FDA) | Once weekly injection |
| Reduce heart attack/stroke risk in T2D | Yes (FDA) | For those with cardiovascular disease |
| Obesity / weight management | Yes (as Wegovy, higher dose) | Also used off-label as Ozempic |
| Kidney protection in T2D | Emerging (approved 2024) | Ozempic brand expanding |
How It Is Given
- Subcutaneous injection (under the skin), once weekly
- Comes in a pre-filled pen injector
- Injected in the abdomen, thigh, or upper arm
Common Side Effects
- Nausea, vomiting, diarrhea, constipation (most common, especially when starting)
- Risk of pancreatitis
- Contraindicated in patients with a history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2)
In short, Ozempic is mainly used for controlling blood sugar in type 2 diabetes, protecting the heart, and promoting weight loss.